ALDEYRA THERAPEUTICS, INC. Earnings Per Share (Basic)
ALDEYRA THERAPEUTICS, INC. (ALDX) reported Earnings Per Share (Basic) of -$0.09 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- ALDEYRA THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.09.
- ALDEYRA THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.06.
- ALDEYRA THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.13.
- ALDEYRA THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$0.16.
- ALDEYRA THERAPEUTICS, INC. earnings per share, basic for fiscal 2025 was -$0.56.
- ALDEYRA THERAPEUTICS, INC. earnings per share, basic for fiscal 2024 was -$0.94.
- ALDEYRA THERAPEUTICS, INC. earnings per share, basic for fiscal 2023 was -$0.64.
- ALDEYRA THERAPEUTICS, INC. earnings per share, basic for fiscal 2022 was -$1.06.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.09 10-Q · filed 2026-08-06 | -$0.15 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | -$0.06 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | -$0.56 10-K · filed 2026-02-27 | |||
| 2025-09-30 | -$0.13 10-Q · filed 2025-11-05 | -$0.46 10-Q · filed 2025-11-05 | ||
| 2025-06-30 | -$0.16 10-Q · filed 2026-08-06 | -$0.33 10-Q · filed 2026-08-06 | ||
| 2025-03-31 | -$0.17 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | -$0.94 10-K · filed 2026-02-27 | |||
| 2024-09-30 | -$0.25 10-Q · filed 2025-11-05 | -$0.67 10-Q · filed 2025-11-05 | ||
| 2024-06-30 | -$0.28 10-Q · filed 2025-08-07 | -$0.42 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | -$0.14 10-Q · filed 2025-05-14 | |||
| 2023-12-31 | -$0.64 10-K · filed 2025-02-28 | |||
| 2023-09-30 | -$0.14 10-Q · filed 2024-11-07 | -$0.56 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | -$0.15 10-Q · filed 2024-08-01 | -$0.42 10-Q · filed 2024-08-01 | ||
| 2023-03-31 | -$0.27 10-Q · filed 2024-05-02 | |||
| 2022-12-31 | -$1.06 10-K · filed 2024-03-07 | |||
| 2022-09-30 | -$0.25 10-Q · filed 2023-11-03 | -$0.84 10-Q · filed 2023-11-03 | ||
| 2022-06-30 | -$0.30 10-Q · filed 2023-08-03 | -$0.59 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | -$0.29 10-Q · filed 2023-05-04 | |||
| 2021-12-31 | -$1.07 10-K · filed 2023-03-09 | |||
| 2021-09-30 | -$0.27 10-Q · filed 2022-11-10 | -$0.80 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | -$0.28 10-Q · filed 2022-08-05 | -$0.52 10-Q · filed 2022-08-05 | ||
| 2016-03-31 | -$0.51 10-Q · filed 2016-05-09 | -$0.96 derived: net income ÷ weighted average shares · filed 2016-05-09 | -$1.31 derived: net income ÷ weighted average shares · filed 2016-05-09 | -$1.59 derived: net income ÷ weighted average shares · filed 2016-05-09 |
| 2015-12-31 | -$0.45 derived: net income ÷ weighted average shares · filed 2016-03-30 | -$0.79 derived: net income ÷ weighted average shares · filed 2016-03-30 | -$1.07 derived: net income ÷ weighted average shares · filed 2016-03-30 | -$1.40 10-K · filed 2016-03-30 |
| 2015-09-30 | -$0.35 10-Q · filed 2015-11-13 | -$0.62 derived: net income ÷ weighted average shares · filed 2015-11-13 | -$0.94 10-Q · filed 2015-11-13 | -$1.34 derived: net income ÷ weighted average shares · filed 2016-05-09 |
| 2015-06-30 | -$0.27 10-Q · filed 2015-08-14 | -$0.58 10-Q · filed 2015-08-14 | -$0.99 derived: net income ÷ weighted average shares · filed 2016-05-09 | -$1.35 derived: net income ÷ weighted average shares · filed 2016-05-09 |
| 2015-03-31 | -$0.32 10-Q · filed 2016-05-09 | -$0.75 derived: net income ÷ weighted average shares · filed 2016-05-09 | -$1.11 derived: net income ÷ weighted average shares · filed 2016-05-09 | -$2.21 derived: net income ÷ weighted average shares · filed 2016-05-09 |
| 2014-12-31 | -$0.44 derived: net income ÷ weighted average shares · filed 2016-03-30 | -$0.80 derived: net income ÷ weighted average shares · filed 2016-03-30 | -$1.97 derived: net income ÷ weighted average shares · filed 2016-03-30 | -$2.51 10-K · filed 2016-03-30 |
| 2014-09-30 | -$0.36 10-Q · filed 2015-11-13 | -$1.58 derived: net income ÷ weighted average shares · filed 2015-11-13 | -$2.21 10-Q · filed 2015-11-13 | -$2.63 derived: net income ÷ weighted average shares · filed 2015-11-13 |
| 2014-06-30 | -$1.43 10-Q · filed 2015-08-14 | -$2.51 10-Q · filed 2015-08-14 | -$3.11 derived: net income ÷ weighted average shares · filed 2015-08-14 | -$3.12 derived: net income ÷ weighted average shares · filed 2015-08-14 |
| 2014-03-31 | -$0.04 10-Q · filed 2015-05-14 | $2.38 derived: net income ÷ weighted average shares · filed 2015-05-14 | $5.11 derived: net income ÷ weighted average shares · filed 2015-05-14 | -$0.19 derived: net income ÷ weighted average shares · filed 2015-05-14 |
| 2013-12-31 | $2.42 derived: net income ÷ weighted average shares · filed 2015-03-23 | $5.17 derived: net income ÷ weighted average shares · filed 2015-03-23 | -$0.15 derived: net income ÷ weighted average shares · filed 2015-03-23 | $3.49 10-K · filed 2015-03-23 |
| 2013-09-30 | $2.76 10-Q · filed 2014-11-12 | -$2.66 derived: net income ÷ weighted average shares · filed 2014-11-12 | $1.00 10-Q · filed 2014-11-12 | |
| 2013-06-30 | -$5.47 10-Q · filed 2014-08-07 | -$18.50 10-Q · filed 2014-08-07 | ||
| 2013-03-31 | -$13.03 10-Q · filed 2014-06-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |